Page last updated: 2024-08-21

3-hydroxyflavone and Liver Dysfunction

3-hydroxyflavone has been researched along with Liver Dysfunction in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Ding, P; Ji, G; Wang, J; Wang, Y; Wu, T; Xiang, H1
Bi, Y; Chen, J; Fu, J; Liu, B; Wang, X; Xia, T; Zhu, R1
Chen, J; Chen, Y; Chi, X; Guo, D; Jiang, Y; Jiang, Z; Lin, J; Lv, L; Pi, H; Qin, W; Yang, H1
Küpeli, E; Orhan, DD; Yesilada, E1
Bioque, G; Closa, D; Gelpí, E; Hotter, G; León, OS; Rósello-Catafau, J; Torres, M1
Cao, J; Chen, T; Jiang, J; Koda, A; Saiki, I; Wu, F; Xu, Q1

Reviews

2 review(s) available for 3-hydroxyflavone and Liver Dysfunction

ArticleYear
Recent update on application of dihydromyricetin in metabolic related diseases.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 148

    Topics: AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Antioxidants; Cell Death; Flavonols; Glucose; Humans; Lipid Metabolism; Liver Diseases; Metabolic Diseases; MicroRNAs; Neoplasms; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction

2022
Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 142

    Topics: Carcinoma, Hepatocellular; Flavonols; Humans; Liver Diseases; Liver Diseases, Alcoholic; Liver Failure, Acute; Liver Neoplasms; Liver Regeneration; Non-alcoholic Fatty Liver Disease; Protective Agents

2021

Other Studies

4 other study(ies) available for 3-hydroxyflavone and Liver Dysfunction

ArticleYear
Dihydromyricetin protects against liver ischemia/reperfusion induced apoptosis via activation of FOXO3a-mediated autophagy.
    Oncotarget, 2016, 11-22, Volume: 7, Issue:47

    Topics: Animals; Apoptosis; Autophagy; Caspase 3; Disease Models, Animal; Flavonols; Forkhead Box Protein O3; Liver Diseases; Mice; Mice, Inbred C57BL; Phosphorylation; Protective Agents; Reperfusion Injury

2016
Effect of Cistus laurifolius L. leaf extracts and flavonoids on acetaminophen-induced hepatotoxicity in mice.
    Journal of ethnopharmacology, 2006, Feb-20, Volume: 103, Issue:3

    Topics: Acetaminophen; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cistus; Flavonoids; Flavonols; Glutathione; Kaempferols; Lipid Peroxidation; Liver; Liver Diseases; Male; Malondialdehyde; Mice; Plant Extracts; Plant Leaves; Quercetin; Turkey

2006
Prostanoids and free radicals in Cl4C-induced hepatotoxicity in rats: effect of astilbin.
    Prostaglandins, leukotrienes, and essential fatty acids, 1997, Volume: 56, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antioxidants; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Dinoprostone; Female; Flavonoids; Flavonols; Free Radicals; Lipid Peroxidation; Liver; Liver Diseases; Malondialdehyde; Molecular Structure; Phospholipases A; Prostaglandins; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thromboxane B2; Vitamin E

1997
Astilbin selectively induces dysfunction of liver-infiltrating cells--novel protection from liver damage.
    European journal of pharmacology, 1999, Jul-14, Volume: 377, Issue:1

    Topics: Animals; Antioxidants; Apoptosis; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; DNA Fragmentation; Drugs, Chinese Herbal; Flavonoids; Flavonols; Hypersensitivity, Delayed; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Picryl Chloride; Spleen; Transaminases

1999